Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

Acupuncture and Pain Processing
Acupuncture and Pain Processing
Status: Archived
mi
from
Stanford, CA
Acupuncture and Pain Processing
Acupuncture and Pain Processing
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Study of T3 for the Treatment of Fibromyalgia
T3 for Fibromyalgia: a Pilot Double-blind Non-randomized Clinical Trial
Status: Archived
mi
from
Stanford, CA
Study of T3 for the Treatment of Fibromyalgia
T3 for Fibromyalgia: a Pilot Double-blind Non-randomized Clinical Trial
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Nutrition and Coping Education for Symptom and Weight Management for Fibromyalgia
Lifestyle Modification Program for Overweight and Obese Fibromyalgia Patients
Status: Archived
mi
from
Salt Lake City, UT
Nutrition and Coping Education for Symptom and Weight Management for Fibromyalgia
Lifestyle Modification Program for Overweight and Obese Fibromyalgia Patients
Status: Archived
Updated: 1/1/1970
Pain Research Center, University of Utah
mi
from
Salt Lake City, UT
Developing Biomarkers for Fibromyalgia
Developing Biomarkers for Fibromyalgia
Status: Archived
mi
from
Ann Arbor, MI
Developing Biomarkers for Fibromyalgia
Developing Biomarkers for Fibromyalgia
Status: Archived
Updated: 1/1/1970
University of Michigan, Chronic Pain and Fatigue Research Center
mi
from
Ann Arbor, MI
Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points
An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
Status: Archived
mi
from
Winston-Salem, NC
Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points
An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
Status: Archived
Updated: 1/1/1970
The Center for Clinical Research
mi
from
Winston-Salem, NC
Self-Directed Exercise Program for Adults With Arthritis
Evaluation of a Self-directed, Packaged Physical Activity Program for Adults With Arthritis
Status: Archived
mi
from
Columbia, SC
Self-Directed Exercise Program for Adults With Arthritis
Evaluation of a Self-directed, Packaged Physical Activity Program for Adults With Arthritis
Status: Archived
Updated: 1/1/1970
University of South Carolina Prevention Research Center
mi
from
Columbia, SC
L-Tyrosine Supplementation in Patients With Fibromyalgia
L-Tyrosine Supplementation in Patients With Fibromyalgia
Status: Archived
mi
from
New York, NY
L-Tyrosine Supplementation in Patients With Fibromyalgia
L-Tyrosine Supplementation in Patients With Fibromyalgia
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Treatment of Fibromyalgia Using Deep Shaped-Field Transcranial Magnetic Stimulation a Clinical Feasibility Study
Treatment of Fibromyalgia Using Deep Shaped-Field (DSF) Transcranial Magnetic Stimulation (TMS): A Clinical Feasibility Study
Status: Archived
mi
from
Peoria, AZ
Treatment of Fibromyalgia Using Deep Shaped-Field Transcranial Magnetic Stimulation a Clinical Feasibility Study
Treatment of Fibromyalgia Using Deep Shaped-Field (DSF) Transcranial Magnetic Stimulation (TMS): A Clinical Feasibility Study
Status: Archived
Updated: 1/1/1970
Premier Research Center
mi
from
Peoria, AZ
Evaluation of Magnetic Fields to Treat Fibromyalgia
A Randomized, Double-blind, Placebo-controlled Evaluation of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Fibromyalgia: Pilot Study Protocol
Status: Archived
mi
from
San Diego, CA
Evaluation of Magnetic Fields to Treat Fibromyalgia
A Randomized, Double-blind, Placebo-controlled Evaluation of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Fibromyalgia: Pilot Study Protocol
Status: Archived
Updated: 1/1/1970
Innovative Research Center of California
mi
from
San Diego, CA
Neurotropin Treatment of Fibromyalgia
Neurotropin Treatment of Fibromyalgia
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Neurotropin Treatment of Fibromyalgia
Neurotropin Treatment of Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia
A Pilot Study of Transcranial Magnetic Stimulation (TMS) Effects on Pain and Depression in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/31/1969
mi
from
Charleston, SC
A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia
A Pilot Study of Transcranial Magnetic Stimulation (TMS) Effects on Pain and Depression in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
An fMRI Study Of Brain Response In Patients With Fibromyalgia
A Double-Blind, Placebo-Controlled Cross-Over Study In Fibromyalgia Subjects To Examine Effects Of Pregabalin On Brain Response To Mechanical Pain As Assessed By Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy And Subjective Ratings
Status: Enrolling
Updated:  12/31/1969
mi
from
Ann Arbor, MI
An fMRI Study Of Brain Response In Patients With Fibromyalgia
A Double-Blind, Placebo-Controlled Cross-Over Study In Fibromyalgia Subjects To Examine Effects Of Pregabalin On Brain Response To Mechanical Pain As Assessed By Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy And Subjective Ratings
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pain Quality Study
Pain Quality in Individuals With Low Back Pain, Headache, and Fibromyalgia
Status: Enrolling
Updated:  12/31/1969
mi
from
Seattle, WA
Pain Quality Study
Pain Quality in Individuals With Low Back Pain, Headache, and Fibromyalgia
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Orange, CA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Andrew O. Schreiber, MD
mi
from
Orange, CA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Santa Ana, CA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Apex Research Institute
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Ocala, FL
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Paddock Park Clinical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Pembroke Pines, FL
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Broward Research Group
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Moline, IL
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Arthritis Care Center
mi
from
Moline, IL
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Indianapolis, IN
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Davis Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Lexington, KY
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Madisonville, KY
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Commonwealth Biomedical Research, LLC
mi
from
Madisonville, KY
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Brockton, MA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Kansas City, MO
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
The Center for Pharmaceutical Research, P.C.
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Omaha, NE
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Las Vegas, NV
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
AB Clinical Trials
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Albuquerque, NM
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Albuquerque Neuroscience, Incorporated
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Brooklyn, NY
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Social Psychiatry Research Institute
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Minot, ND
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Trinity Health Organization
mi
from
Minot, ND
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Dayton, OH
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Medford, OR
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Altoona, PA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Allegheny Pain Management
mi
from
Altoona, PA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethlehem, PA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
East Penn RheumatologyAssociates, P.C.
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Lake Jackson, TX
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
R/D Clinical Research, Inc.
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Salt Lake City, UT
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
The Fatigue Consultation Clinic
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Tacoma, WA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Tacoma Center for Arthritis Research, PS
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Tampa, FL
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Columbus, OH
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashville, TN
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Charlottesville, VA
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Inc.
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Penticton,
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Dr. Alexander McIntyre Inc.
mi
from
Penticton,
Click here to add this to my saved trials
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245)
Status: Enrolling
Updated: 12/31/1969
Mercy Health Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)
Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)
Status: Enrolling
Updated:  12/31/1969
mi
from
Iowa City, IA
Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)
Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)
Status: Enrolling
Updated: 12/31/1969
University of Iowa - Physical Therapy and Rehabilitation Science
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
NoesisPharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Cromwell, CT
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Trials LLC
mi
from
Cromwell, CT
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Smyrna, GA
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Nashua, NH
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated:  12/31/1969
mi
from
Albuquerque, NM
A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome
Status: Enrolling
Updated: 12/31/1969
Albuquerque Neurosciences
mi
from
Albuquerque, NM
Click here to add this to my saved trials